Today's Technical View on AstraZeneca, GlaxoSmithKline, PDL BioPharma, and Herbalife

LONDON, April 1, 2013 /PRNewswire/ --

One of the biggest trends to emerge in the healthcare sector in the last year has been increasing competition from generic drugs. In 2012, patent on several blockbuster drugs expired, leading to increasing generic competition for drug manufacturers such as AstraZeneca Plc (NYSE: AZN), GlaxoSmithKline Plc (NYSE: GSK), and PDL BioPharma Inc. (NASDAQ: PDLI). The trend is expected to continue in 2013. The key for drug manufacturers will be to boost their product pipeline. Innovation will also be important for drug related products manufacturers such as Herbalife Ltd. (NYSE: HLF). On Thursday, healthcare stocks ended mostly higher, tracking gains in the broad market. StockCall initiated free in-depth technical analysis on AZN, GSK, PDLI, and HLF which are currently available upon sign up at

http://www.stockcall.com/research

Shares of AstraZeneca Plc rose sharply in Thursday's trading session. The stock rose to an intra-day high of $50.12 before finishing the day 1.54% higher at $49.98. AstraZeneca's shares are currently trading close to their 52-week high of $50.14. The stock has had an excellent run so far in 2013, gaining more than 10%. The company's shares currently have a dividend yield of 7.60%. The company's shares have seen a series of highs in the last few sessions, which is a bullish signal. The stock has also broken through $47.50 resistance level, which further confirms the upbeat trend. Sign up for the free technical analysis on AZN at

http://www.StockCall.com/AZN040113.pdf

GlaxoSmithKline Plc's shares are also currently trading near their 52-week high of $47.69. On Thursday, the stock touched an intra-day high of $47.08 before finishing the day 1.14% higher at $46.91. GlaxoSmithKline's shares have gained more than 9.50% in 2013 so far, compared to a gain of more than 10% for the S&P 500. The company currently has a dividend yield of 5.88%. The company's shares have been gaining momentum over the past few trading sessions which indicate that market sentiment is bullish on the stock. The positive trend is further confirmed by the stock's MACD chart. Download the free report on GSK by registering at

http://www.StockCall.com/GSK040113.pdf

PDL BioPharma Inc. is one of the highest divided yielding stocks in the healthcare sector. The stock currently has a dividend yield of 8.22%. Shares of PDL BioPharma edged higher in trading on Thursday. The stock closed 0.97% higher at $7.30 after touching an intra-day high of $7.34. The company's shares are currently trading nearly 10% below their 52-week high of $8.09. The stock has seen a series of highs since February. The stock is also trading above its 50-day and 200-day moving averages, which is a bullish signal. The stock's MACD is currently trading above the signal line and the zero-line, further confirming the positive trend. The free report on PDLI can be downloaded by signing up now at

http://www.StockCall.com/PDLI040113.pdf

Shares of Herbalife Ltd. struggled in trading on Thursday even as the broad market edged higher. The stock ended the day 0.87% lower at $37.45 after touching an intra-day low of $37.24. Herbalife's shares are trading nearly 50% below their 52-week high of $73. The stock, however, has had a decent run so far this year. Year-to-date, shares of HLF have gained more than 14.50%. Herbalife currently has a dividend yield of 3.20%. The company's shares are currently trading below their 50-day and 200-day moving averages, which is a bearish signal. The downbeat trend is further confirmed by the stock's MACD chart. Herbalife Ltd's shares have support at around $37. Free report on HLF can be accessed by registering at

http://www.StockCall.com/HLF040113.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com  

SOURCE StockCall.com




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.